---
aliases: /news/how-digital-therapeutics-can-go-mainstream-in-fragmented-u-s-healthcare
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - How digital therapeutics can go mainstream in fragmented U.S. healthcare
categories:
  - 'Symplur: Digital Therapeutics'
categorySlug:
  - 'symplur: digital therapeutics'
categoryUrl:
  - topic/symplur-digital-therapeutics
categoryLabel:
  - Digital Therapeutics
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-10-09'
description: >-
  There are many stakeholders interested in digital therapeutics, but aligning
  under the common goal of patient needs is key.Over the last decade, digital
  therapeutics have been gaining steam. In part, 
favIconImage: null
featuredImage:
  alt: How digital therapeutics can go mainstream in fragmented U.S. healthcare
  format: JPEG
  href: 1f6dda18-23b8-56c0-9edd-333b06b80be7-featuredImage.jpeg
  size:
    - 630
    - 1200
  valid: true
  workPackage: 8197
  wpAttachment:
    fileName: Curated_Featured_Image.JPG
    link: /api/v3/attachments/17804/content
featuredPdf: null
htmlMetaData:
  author: null
  description: >-
    There are many stakeholders interested in digital therapeutics, but aligning
    under the common goal of patient needs is key.
  generator: 'Drupal 7 (http://drupal.org)'
  viewport: 'width=device-width, initial-scale=1.0'
  articlemodified_time: '2021-09-28T15:34:37-04:00'
  articlepublished_time: '2021-09-28T14:38:34-04:00'
  msvalidate.01: E23E222F362070D7E155C1DCE851E7E9
  ogdescription: >-
    There are many stakeholders interested in digital therapeutics, but aligning
    under the common goal of patient needs is key.
  ogimage: >-
    https://www.mobihealthnews.com/sites/default/files/app%20sick%20%28Courtney%20Hale%29_0.JPG
  ogsite_name: MobiHealthNews
  ogtitle: How digital therapeutics can go mainstream in fragmented U.S. healthcare
  ogtype: article
  ogupdated_time: '2021-09-28T15:34:37-04:00'
  ogurl: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
  yandex-verification: f18b253cb47f85eb
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: F0c38at4EUXC1BvxWmtxK1X8nm-XFctV2t3TvhaB7L8
  keywords: null
id: 8197
identifier: News
lastMod: '2021-10-09T17:55:15.719193Z'
link:
  brand: mobihealthnews.com
  href: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
  original: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
href: >-
  https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
original: >-
  https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
mastHead: NEWS
mdName: 1f6dda18-23b8-56c0-9edd-333b06b80be7.md
openGraphMetaData:
  ogdescription: >-
    There are many stakeholders interested in digital therapeutics, but aligning
    under the common goal of patient needs is key.
  ogtitle: How digital therapeutics can go mainstream in fragmented U.S. healthcare
  ogurl: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
  ogimage: >-
    https://www.mobihealthnews.com/sites/default/files/app%20sick%20%28Courtney%20Hale%29_0.JPG
  ogsite_name: MobiHealthNews
  ogtype: article
  ogupdated_time: '2021-09-28T15:34:37-04:00'
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
  medigyTopics:
    - 'Symplur: Digital Therapeutics'
  sourceUrl: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  mobihealthnews-how-digital-therapeutics-can-go-mainstream-in-fragmented-u-s-healthcare
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: How digital therapeutics can go mainstream in fragmented U.S. healthcare
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: GrayMatters Prism
    permalink: /offering/graymatters-prism
    categories:
      - 'Symplur: Digital Therapeutics'
      - 'Medigy: Mental Health'
    offeringId: 17295
  - label: Renalis CeCe®
    permalink: /offering/renalis-cece-r
    categories:
      - 'Symplur: Digital Therapeutics'
    offeringId: 16352
  - label: metaMe Preion Digital Therapeutics
    permalink: /offering/metame-preion-digital-therapeutics
    categories:
      - 'Symplur: Digital Therapeutics'
      - 'Medical Subject Headings (MeSH): Prescriptions'
    offeringId: 15957
  - label: Daylight
    permalink: /offering/daylight
    categories:
      - 'Symplur: Digital Therapeutics'
    offeringId: 9503
  - label: Oleena®
    permalink: /offering/oleena-r
    categories:
      - 'KLAS: Oncology Treatment Planning'
      - 'Healthcare IT News: Remote Patient Monitoring'
      - 'Symplur: Digital Therapeutics'
    offeringId: 6401
twitterMetaData:
  twittercard: summary_large_image
  twitterdescription: >-
    There are many stakeholders interested in digital therapeutics, but aligning
    under the common goal of patient needs is key.
  twittertitle: How digital therapeutics can go mainstream in fragmented U.S. healthcare
  twitterimage: >-
    https://www.mobihealthnews.com/sites/default/files/app%20sick%20%28Courtney%20Hale%29_0.JPG
  twitterurl: >-
    https://www.mobihealthnews.com/news/how-digital-therapeutics-can-go-mainstream-fragmented-us-healthcare
---
<p>There are many stakeholders interested in digital therapeutics, but aligning under the common goal of patient needs is key.<br><br>Over the last decade, digital therapeutics have been gaining steam. In part, this shift is aided by the adoption of connected medical tools during the COVID-19 pandemic and the ongoing push toward&nbsp;more of a hybrid care model. However, the technologies have largely not yet hit the mainstream market.</p><p>Today, industry players are looking to get stakeholders from the provider, payer and life science industries&nbsp;onboard.&nbsp;</p>